Japan — Revenue
Geographic · RevenueEli Lilly Japan — Revenue increased by 17.9% to $654.10M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 17.0%, from $559.20M to $654.10M. Over 4 years (FY 2021 to FY 2025), Japan — Revenue shows relatively stable performance with a -2.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful product launches, strong market demand, or favorable pricing dynamics in Japan, while a decrease may signal increased competition, pricing pressure from government health authorities, or supply chain constraints.
Detailed definition
This metric represents the total net sales generated from pharmaceutical products sold within the Japanese geographic ma...
Peer comparison
Comparable to regional revenue segments reported by other multinational pharmaceutical companies, often evaluated against local market growth rates and currency fluctuations.
lly_segment_jp_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $665.40M | $595.00M | $534.80M | $410.20M | $454.40M | $487.70M | $395.00M | $387.20M | $455.60M | $390.80M | $439.00M | $363.90M | $462.70M | $429.10M | $559.20M | $402.20M | $521.00M | $554.70M | $654.10M |
| QoQ Change | — | -10.6% | -10.1% | -23.3% | +10.8% | +7.3% | -19.0% | -2.0% | +17.7% | -14.2% | +12.3% | -17.1% | +27.2% | -7.3% | +30.3% | -28.1% | +29.5% | +6.5% | +17.9% |
| YoY Change | — | — | — | — | -31.7% | -18.0% | -26.1% | -5.6% | +0.3% | -19.9% | +11.1% | -6.0% | +1.6% | +9.8% | +27.4% | +10.5% | +12.6% | +29.3% | +17.0% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Eli Lilly's japan — revenue?
- Eli Lilly (LLY) reported japan — revenue of $654.10M in Q4 2025.
- How has Eli Lilly's japan — revenue changed year-over-year?
- Eli Lilly's japan — revenue increased by 17.0% year-over-year, from $559.20M to $654.10M.
- What is the long-term trend for Eli Lilly's japan — revenue?
- Over 4 years (2021 to 2025), Eli Lilly's japan — revenue has grown at a -2.6% compound annual growth rate (CAGR), from $2.37B to $2.13B.
- What does japan — revenue mean?
- The total revenue generated from sales of pharmaceutical products in Japan.